In MCF7 (ER+ AR+) xenograft tumors, enzalutamide blocked E2–driven tumor proliferation as strongly as tamoxifen, suggesting that high AR/ER may not simply result from low ER expression, but that AR itself does play a role in tumor cell proliferation. Here, AR is linked to neoplasm.